Meanwhile, dose intensity, history of cholelithiasis, ALT, AST and Hb were related risk factors of HFS: reductions of dose intensity and WBC was a related risk factor of OM, and reductions of dose intensity, history of cholelithiasis and WBC was a related risk factor of simultaneous incidence of HFS and OM. This evidence concerns the gene GSTM1 and Hand-foot syndrome.